The development and FDA approval of the new anti-androgens, Zytiga (abiraterone), Xtandi (enzalutamide) and Erleada (apalutamide), represent a major advance in prostate cancer treatment. This issue … more

This month's issure talks about Erectile Dysfunction After Treatment. Following is a link to this month's issues and a list of all the articles. 

P4 Talking About Erectile Dysfunction

P6 David … more

This month’s issue of Prostatepedia talks about Chemotherapy. Most think that once the cancer has metastasized and one starts Chemotherapy the best results only mean extending life for a year or … more

P4 Frontiers in Radiation Therapy P6 Anthony D’Amico, MD Guest Commentary

P8 Robert Bristow, MD, PhD, FRCPC Precision Radiotherapy

P14 Charles Drake, MD Radiation, Immunotherapy + the Abscopal … more

P4 Collaborating For Prostate Cancer

P6 Paul Nguyen, MD Health/Tech Collaborations For Prostate Cancer P10 Felix Y. Feng, MD Tech World Helps Prostate Cancer Manage Big Data

P14 John Wilbanks Join … more

P4 Clinical Trials + You

P6 Fred Saad, MD How I Talk To My Patients About Clinical Trials

P10 Jonathan Simons, MD Funding Clinical Trials

P14 Ravi Madan, MD Clinical Trials + Prostate Cancer … more

This month’s Prostatepedia talks about Genomics and how it is changing the way Prostate Cancer is being treated. For the most part,  Gemomic testing involves finding the genes that are expressing … more

Read March's Issue more